3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Tuberous Sclerosis
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Disease
1
Interventions
Everolimus
12
Sirolimus
10
Cannabidiol
3
ganaxolone
2
Melatonin
2
Activator Appliances
2
radiprodil
1
Vigabatrin
1
Urination
1
Simvastatin
1
Propranolol
1
Doxycycline
1
Calcitriol
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Tuberous Sclerosis
×
Urination
×
Clear all
NCT05323370
2023-03-29
LAM-CAK
University Hospital, Tours
Completed
19 enrolled